Queen Mary University of London

Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial (2024) Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder R, et al. Journal article Exploiting Active RIS in NOMA Networks With Hardware Impairments (2024) Yue X, Song M, Ouyang C, Liu Y, Li T, Hou T Journal article Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program (2024) Azizi M, Sharp AS, Fisher ND, Weber MA, Lobo MD, Daemen J, Lurz P, et al. Journal article Precursor-Engineered Volatile Inks Enable Reliable Blade-Coating of Cesium–Formamidinium Perovskites Toward Fully Printed Solar Modules (2024) Du T, Rehm V, Qiu S, Pal S, Jang D, Peng Z, Zhang J, et al. Journal article European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes) (2024) Kandolf L, Peris K, Malvehy J, Mosterd K, Heppt M, Fargnoli MC, Berking C, et al. Journal article Correction to: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension (PharmacoEconomics - Open, (2024), 10.1007/s41669-024-00472-z) (2024) Taylor RS, Bentley A, Metcalfe K, Lobo MD, Kirtane AJ, Azizi M, Clark C, et al. Journal article, Erratum Performance Analysis and Low-Complexity Design for XL-MIMO with Near-Field Spatial Non-Stationarities (2024) Zhi K, Pan C, Ren H, Chai KK, Wang CX, Schober R, You X Journal article Upadacitinib Achieves Clinical and Endoscopic Outcomes in Crohn's Disease Regardless of Prior Biologic Exposure (2024) Peyrin-Biroulet L, Panaccione R, Louis E, Atreya R, Rubin DT, Lindsay JO, Siffledeen J, et al. Journal article Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 (2024) Pusztai L, Denkert C, O'Shaughnessy J, Cortes J, Dent R, McArthur H, Kümmel S, et al. Journal article